Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-06-18

Neuroprotective strategies for multiple sclerosis

Objective

Despite intensive research on the causes and pathogenesis of multiple sclerosis (MS), the genetic basis of this common cause of neurological disability is still unknown and the complex immunopathological mechanisms underlying brain injury are only beginning to be understood. To date, no curative therapy is available and none of the existing drugs can stop the neurodegenerative process responsible for disease progression. The NeuroproMiSe project represents a highly focussed and integrated effort to investigate in depth the genetic and mechanistic pathways involved in inflammation-induced neurodegeneration, and exploit this knowledge to develop novel candidate drugs for effective neuroprotective therapy. NeuroproMiSe specific objectives are: 1) To identify the major genes and critical pathways associated with MS and inflammatory neurodegeneration. This goal will be achieved through a comparative genetic approach, using an established animal platform suitable for identification of EAE susceptibility genes, and well-characterized, ethnically homogeneous cohorts of MS patients. Through genomic and proteomic screens carried out in animal disease models, further knowledge will be obtained on genes and molecular pathways involved in inflammatory neurodegeneration. 2) To elucidate essential immunopathological mechanisms of neurodegeneration, focussing on innate and adaptive immune responses and on the use of humanized animal models to define new rational ways of developing disease modifying drugs. 3) To develop novel neuroprotective drugs based on targets validated in animal models. In a first step, new therapeutics targeting critical pathways (Ncf-1, TREM-2, TNFR subtypes, ion channels, glutamate receptors, apoptosis) identified by the applicants will be tested and used in combination therapies. The project is conducted in alliance with four SMEs and has potential for direct transfer of basic research results into clinical studies and economic and society benefits.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

FP6-2004-LIFESCIHEALTH-5
See other projects for this call

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

IP - Integrated Project

Coordinator

ISTITUTO SUPERIORE DI SANITÀ
EU contribution
No data
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (24)

My booklet 0 0